New Zealand markets closed

Viatris Inc. (VTRS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
11.94+0.11 (+0.93%)
At close: 04:00PM EDT
12.00 +0.06 (+0.50%)
After hours: 07:02PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close11.83
Open11.81
Bid11.90 x 3200
Ask11.94 x 6400
Day's range11.77 - 12.02
52-week range8.74 - 13.62
Volume11,455,574
Avg. volume10,201,652
Market cap14.18B
Beta (5Y monthly)1.14
PE ratio (TTM)238.80
EPS (TTM)0.05
Earnings date06 May 2024 - 10 May 2024
Forward dividend & yield0.48 (4.06%)
Ex-dividend date08 Mar 2024
1y target est15.00
  • PR Newswire

    Viatris Hosts R&D Event Focusing on its Collaboration with Idorsia, Phase 3 Assets Selatogrel and Cenerimod and Key Elements of its Pipeline

    At a meeting with the investment community today, Viatris Inc. (NASDAQ: VTRS), a global healthcare company, will outline how it is continuing to evolve its R&D strategy to deliver on its goal of building a more durable, higher-margin portfolio of patented innovation on the foundation of its strong base business. The focus of the event will be a discussion of its collaboration with Idorsia, Phase 3 assets selatogrel and cenerimod and key elements of the Company's pipeline.

  • Reuters

    UPDATE 2-US FDA declines to approve Viatris's injection for multiple sclerosis

    The U.S. FDA has declined to approve Viatris and Mapi Pharma's once-a-month injection for treating relapsing forms of debilitating neurological condition multiple sclerosis (MS), the companies said on Monday. The companies were reviewing the content of the health regulator's so called complete response letter (CRL) and would soon determine the appropriate next steps, they said, without disclosing further details. Mapi Pharma did not immediately respond to Reuters requests for additional details on the contents of the CRL, which indicates that an application would not be approved in its present form and requires more information.

  • GuruFocus.com

    Viatris Inc's Dividend Analysis

    Viatris Inc (NASDAQ:VTRS) recently announced a dividend of $0.12 per share, payable on 2024-03-18, with the ex-dividend date set for 2024-03-08. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's delve into Viatris Inc's dividend performance and assess its sustainability.